MAPLE ACCESS PARTNERSHIP LLP — All Prescriptions & Medications — Page 4
Practice Code: K83621 | NORTHAMPTON, NN1 1LG
Showing results 151-200 of 521
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Dexamethasone | 192 | 965 | £602 | +11.7% ▲ |
| Digoxin | 188 | 3,961 | £292 | -50.3% ▼ |
| Clotrimazole | 184 | 4,020 | £250 | +89.9% ▲ |
| Alfacalcidol | 180 | 5,850 | £1.1K | +45.5% ▲ |
| Pravastatin sodium | 179 | 2,807 | £138 | -44.9% ▼ |
| Haloperidol | 178 | 4,247 | £6.9K | +273.7% ▲ |
| Buspirone hydrochloride | 175 | 5,774 | £702 | +247.4% ▲ |
| Donepezil hydrochloride | 172 | 4,792 | £4.9K | -44.3% ▼ |
| Mesalazine (Systemic) | 171 | 13.3K | £7.5K | -28.6% ▼ |
| Isophane insulin | 171 | 814 | £3.5K | +62.0% ▲ |
| Insulin degludec | 171 | 899 | £12.5K | +55.6% ▲ |
| Combined ethinylestradiol 30mcg | 169 | 13.2K | £733 | -39.2% ▼ |
| Chlorphenamine maleate | 168 | 17.2K | £550 | +52.2% ▲ |
| Pancreatin | 166 | 30.9K | £7.5K | +49.3% ▲ |
| Azathioprine | 163 | 7,266 | £167 | +50.4% ▲ |
| Insulin glargine | 161 | 777 | £5.6K | -43.3% ▼ |
| Fentanyl | 160 | 695 | £3.7K | +56.2% ▲ |
| Semaglutide | 160 | 1,175 | £11.9K | -33.6% ▼ |
| Perindopril erbumine | 156 | 3,396 | £325 | -70.6% ▼ |
| Methocarbamol | 155 | 10.2K | £677 | +223.8% ▲ |
| Peppermint oil | 154 | 6,352 | £622 | +93.5% ▲ |
| Carbimazole | 154 | 6,020 | £459 | +36.3% ▲ |
| Ketone blood testing reagents | 153 | 1,920 | £1.8K | +126.1% ▲ |
| 152 | 1,570 | £335 | -27.3% ▼ | |
| Loperamide hydrochloride | 151 | 8,051 | £172 | -35.2% ▼ |
| Bumetanide | 151 | 5,235 | £518 | -44.6% ▼ |
| Chlorpromazine hydrochloride | 151 | 2,478 | £1.5K | +283.9% ▲ |
| Glucose | 151 | 8,215 | £751 | +190.4% ▲ |
| Carvedilol | 150 | 3,556 | £117 | +32.2% ▲ |
| Lisdexamfetamine dimesylate | 149 | 4,382 | £10.7K | +24.8% ▲ |
| Clotrimazole | 148 | 895 | £1.1K | +34.1% ▲ |
| Enoxaparin | 147 | 2,272 | £12.5K | +617.2% ▲ |
| Hydroxocobalamin | 146 | 157 | £338 | -69.7% ▼ |
| Nystatin | 145 | 4,590 | £263 | +43.8% ▲ |
| Betamethasone esters | 144 | 7,580 | £1.1K | +138.7% ▲ |
| Sennosides | 140 | 51.0K | £999 | +353.3% ▲ |
| Tirzepatide | 140 | 140 | £13.5K | -27.9% ▼ |
| Fenofibrate | 139 | 3,157 | £368 | +43.6% ▲ |
| Zolpidem tartrate | 138 | 1,182 | £63 | +53.2% ▲ |
| Fluticasone furoate | 137 | 137 | £977 | -29.3% ▼ |
| Lercanidipine hydrochloride | 134 | 2,439 | £226 | -78.3% ▼ |
| Chloramphenicol | 133 | 1,278 | £639 | +16.1% ▲ |
| Estradiol with progestogen | 132 | 4,590 | £2.5K | -61.3% ▼ |
| Fluticasone propionate (Inhalation) | 130 | 139 | £4.0K | -66.4% ▼ |
| Betahistine hydrochloride | 129 | 6,930 | £211 | -46.0% ▼ |
| Enalapril maleate | 128 | 4,060 | £117 | -28.8% ▼ |
| Ticagrelor | 127 | 4,898 | £4.8K | +49.3% ▲ |
| Letrozole | 126 | 2,436 | £223 | -32.5% ▼ |
| Insulin detemir | 124 | 735 | £6.2K | +58.3% ▲ |
| Mometasone furoate | 123 | 123 | £973 | -69.4% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.